Staphylococcus
Related VF: TSST-1 (Toxic shock syndrome toxin-1)
Target: SaeS
Drug effect: Inhibits the kinase activity of SaeS to repress exotoxin production.
Max phase: Preclinical (in vitro)
Publication: Dufresne K, et al., 2024. Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production. J Biol Chem 300(7):107455.